Wellington Management Group LLP Has $1.25 Billion Stock Holdings in Agilent Technologies, Inc. (NYSE:A)

Wellington Management Group LLP boosted its position in Agilent Technologies, Inc. (NYSE:A - Free Report) by 0.6% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 9,306,805 shares of the medical research company's stock after buying an additional 59,781 shares during the quarter. Wellington Management Group LLP owned approximately 3.26% of Agilent Technologies worth $1,250,276,000 at the end of the most recent reporting period.

Other institutional investors have also recently bought and sold shares of the company. O Shaughnessy Asset Management LLC grew its stake in shares of Agilent Technologies by 9.8% in the fourth quarter. O Shaughnessy Asset Management LLC now owns 37,177 shares of the medical research company's stock worth $4,994,000 after acquiring an additional 3,327 shares during the last quarter. CIBC Private Wealth Group LLC raised its stake in Agilent Technologies by 1.2% during the 4th quarter. CIBC Private Wealth Group LLC now owns 7,479 shares of the medical research company's stock valued at $1,025,000 after purchasing an additional 87 shares during the last quarter. Schroder Investment Management Group boosted its holdings in Agilent Technologies by 0.5% in the 4th quarter. Schroder Investment Management Group now owns 88,300 shares of the medical research company's stock valued at $11,847,000 after purchasing an additional 405 shares during the period. Allstate Corp acquired a new stake in Agilent Technologies in the 4th quarter worth $1,144,000. Finally, Brown Brothers Harriman & Co. increased its holdings in shares of Agilent Technologies by 59.9% during the 4th quarter. Brown Brothers Harriman & Co. now owns 1,033 shares of the medical research company's stock worth $139,000 after purchasing an additional 387 shares during the period. Institutional investors own 87.42% of the company's stock.

Remove Ads

Insiders Place Their Bets

In related news, Director Daniel K. Podolsky sold 1,819 shares of the stock in a transaction that occurred on Monday, March 31st. The stock was sold at an average price of $116.46, for a total transaction of $211,840.74. Following the completion of the sale, the director now directly owns 35,737 shares of the company's stock, valued at approximately $4,161,931.02. This represents a 4.84 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Padraig Mcdonnell sold 1,911 shares of Agilent Technologies stock in a transaction that occurred on Tuesday, January 21st. The shares were sold at an average price of $150.00, for a total transaction of $286,650.00. Following the completion of the transaction, the chief executive officer now directly owns 39,652 shares in the company, valued at approximately $5,947,800. The trade was a 4.60 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 5,638 shares of company stock worth $731,229. Company insiders own 0.26% of the company's stock.

Analyst Ratings Changes

Several research firms recently weighed in on A. Barclays upgraded shares of Agilent Technologies from an "underweight" rating to an "equal weight" rating and increased their target price for the company from $135.00 to $145.00 in a research note on Monday, February 10th. Robert W. Baird reduced their target price on Agilent Technologies from $161.00 to $159.00 and set an "outperform" rating for the company in a research report on Thursday, February 27th. Bank of America dropped their price objective on shares of Agilent Technologies from $153.00 to $150.00 and set a "neutral" rating for the company in a research note on Friday, December 13th. Citigroup upped their target price on shares of Agilent Technologies to $165.00 and gave the company a "buy" rating in a research note on Thursday, December 19th. Finally, Wells Fargo & Company cut their price target on shares of Agilent Technologies from $157.00 to $155.00 and set an "overweight" rating for the company in a research note on Monday, December 9th. Seven equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to data from MarketBeat, Agilent Technologies currently has an average rating of "Moderate Buy" and an average target price of $150.83.

Agilent Technologies Trading Down 6.1 %

A traded down $6.70 during trading on Friday, reaching $102.97. 3,826,290 shares of the company's stock were exchanged, compared to its average volume of 1,797,502. The company's fifty day moving average price is $130.34 and its 200-day moving average price is $135.75. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.66 and a current ratio of 2.20. The firm has a market capitalization of $29.36 billion, a PE ratio of 23.67, a P/E/G ratio of 3.26 and a beta of 1.19. Agilent Technologies, Inc. has a fifty-two week low of $102.85 and a fifty-two week high of $155.35.

Agilent Technologies (NYSE:A - Get Free Report) last released its quarterly earnings data on Wednesday, February 26th. The medical research company reported $1.31 EPS for the quarter, beating analysts' consensus estimates of $1.27 by $0.04. The business had revenue of $1.68 billion during the quarter, compared to the consensus estimate of $1.67 billion. Agilent Technologies had a return on equity of 25.56% and a net margin of 19.27%. As a group, equities analysts forecast that Agilent Technologies, Inc. will post 5.57 EPS for the current year.

Agilent Technologies Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 23rd. Investors of record on Tuesday, April 1st will be issued a dividend of $0.248 per share. This represents a $0.99 dividend on an annualized basis and a yield of 0.96%. The ex-dividend date is Tuesday, April 1st. Agilent Technologies's dividend payout ratio is currently 22.76%.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.